US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)

Publisher Name :
Date: 07-Nov-2019
No. of pages: 87
Inquire Before Buying

The U.S. OAB market is estimated to reach US$ 3.49 billion in 2031, growing at a CAGR of 5.01%, for the period spanning from 2021-2031. The factors such as rising ageing population, increasing healthcare expenditure, growing obese population, surging diabetic prevalence, increasing coffee consumption and accelerating economic growth are expected to drive the market growth. However, growth of the industry would be challenged by entry of generic drugs, stringent regulations, associated business risk and side effects of oral therapies. A few notable trends include advancing innovative therapies, rising awareness of overactive bladder, growing adoption of procedural (third line) therapy, development of gene therapy and progressing drug pipeline.

The three main treatment approaches for the treatment of overactive bladder are behavioural therapy (Bladder Training & Pelvic Floor Exercises), prescription therapy (Oral Anticholinergics & β3 Adrenoreceptor Agonist) and procedural therapy (BOTOX & Neuromodulation).

The fastest growing market is the U.S. owing to continuous advancement in β3 Adrenoreceptor Agonist drugs, increasing OAB population and growing research & development efforts by domestic pharmaceutical firms to launch novel drugs with innovative mechanism of actions drugs.

Scope of the report:


  • The report provides a comprehensive analysis of the U.S. OAB market, segmented on the basis of drug class i.e. Anticholinergics and β3 Adrenoreceptor Agonist and drug type i.e. Vibegron and Mirabegron.

  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players [Allergan Plc, Pfizer Inc., Astellas Pharma Inc., Hisamitsu Pharmaceutical Co., Inc., Medtronic Plc and Sumitomo Chemical Co., Ltd. (Urovant Sciences Ltd.)] are also presented in detail.


Key Target Audience:


  • Drug Manufacturers

  • Raw Material Suppliers

  • End Users

  • Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)

Table of Contents

1. Market Overview
1.1 Overactive Bladder
1.2 Symptoms & Diagnosis
1.3 Treatment
1.4 Overactive Bladder with BPH

2. The U.S. Market Analysis
2.1 Overactive Bladder Market
2.1.1 The U.S. Overactive Bladder Market Value Forecast
2.1.2 The U.S. Overactive Bladder Market Value by Drug Class
2.1.3 The U.S. Anticholinergics Market Value Forecast
2.1.4 The U.S. β3 Adrenoreceptor Agonists Market Value Forecast
2.1.5 The U.S. β3 Adrenoreceptor Agonists Market Value by Drug Type
2.1.6 The U.S. Vibegron Drug Revenue Forecast
2.1.7 The U.S. Overactive Bladder Patient Population Forecast
2.1.8 The U.S. Overactive Bladder Treated Patient Population Forecast
2.1.9 The U.S. Overactive Bladder Prescriptions Forecast
2.1.10 The U.S. Vibegron Drug Prescriptions Forecast
2.1.11 The U.S. Mirabegron Drug Prescriptions Forecast
2.2 Overactive Bladder Market with BPH
2.2.1 The U.S. Overactive Bladder with BPH Patient Population Forecast
2.2.2 The U.S. β3 Adrenoreceptor Agonist Market by Penetration Rate
2.2.3 The U.S. β3 Adrenoreceptor Agonist Patient Penetration by Drug
2.2.4 The U.S. Vibegron Drug Revenue Forecast
2.2.5 The U.S. Vibegron Prescriptions Forecast
2.2.6 The U.S. Mirabegron Prescriptions Forecast

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Rising Ageing Population
3.1.2 Increasing HealthCare Expenditure
3.1.3 Growing Obese Population
3.1.4 Surging Diabetic Prevalence
3.1.5 Increasing Coffee Consumption
3.1.6 Accelerating Economic Growth
3.2 Key Trends and Developments
3.2.1 Advancing Innovative Therapies
3.2.2 Rising Awareness of Overactive Bladder
3.2.3 Growing Adoption of Procedural (Third Line) Therapy
3.2.4 Development of Gene Therapy
3.2.5 Progressing Drug Pipeline
3.3 Challenges
3.3.1 Entry of Generic Drugs
3.3.2 Stringent Regulations
3.3.3 Associated Business Risk
3.3.4 Side Effects of Oral Therapies

4. Competitive Landscape
4.1 Global OAB Market
4.1.1 Key Players – Revenue Comparison
4.1.2 Key Players – Market Cap Comparison
4.1.3 Key Players – Research & Development Expenditure Comparison

5. Company Profiles
5.1 Allergan Plc
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Pfizer Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Astellas Pharma Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
5.4 Hisamitsu Pharmaceutical Co., Inc.
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
5.5 Medtronic Plc
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Business Strategies
5.6 Sumitomo Chemical Co., Ltd. (Urovant Sciences Ltd.)
5.6.1 Business Overview
5.6.2 Financial Overview
5.6.3 Business Strategies

List of Tables

Overactive Bladder Drug Pipeline (2019-2023)
Key Players – Revenue Comparison (2018)
Pfizer Inc. Segments Overview
Astellas Pharma Segment Overview
Medtronic Segment Overview
Sumitomo Chemical (Urovant Sciences) Segment Overview

List of Figures

Normal Bladder vs. Overactive Bladder
OAB Treatment Approaches
The U.S. Overactive Bladder Market Value Forecast (2021-2031)
The U.S. Overactive Bladder Market Value by Drug Class (2021/2031)
The U.S. Anticholinergics Market Value Forecast (2021-2031)
The U.S. β3 Adrenoreceptor Agonists Market Value Forecast (2021-2031)
The U.S. β3 Adrenoreceptor Agonists Market Value by Drug Type (2021/2031)
The U.S. Vibegron Drug Revenue Forecast (2021-2031)
The U.S. Overactive Bladder Patient Population Forecast (2021-2031)
The U.S. Overactive Bladder Treated Patient Population Forecast (2021-2031)
The U.S. Overactive Bladder Prescriptions Forecast (2021-2031)
The U.S. Vibegron Drug Prescriptions Forecast (2021-2031)
The U.S. Mirabegron Drug Prescriptions Forecast (2021-2031)
The U.S. Overactive Bladder with BPH Patient Population Forecast (2021-2031)
The U.S. β3 Adrenoreceptor Agonist Market by Penetration Rate (2021-2031)
The U.S. β3 Adrenoreceptor Agonist Patient Penetration by Drug (2021/2025/2031)
The U.S. Vibegron Drug Revenue Forecast (2021-2031)
The U.S. Vibegron Prescriptions Forecast (2021-2031)
The U.S. Mirabegron Prescriptions Forecast (2021-2031)
The U.S. Ageing Population (2014-2018)
The U.S. HealthCare Expenditure (1990-2020)
The U.S. Obese Population (2014-2018)
The U.S. Diagnosed Diabetic Population (2014-2018)
The U.S. Coffee Consumption Volume (2014-2018)
The U.S. GDP per Capita (2014-2018)
Key Players – Market Cap Comparison (2019)
Key Players – Research & Development Expenditure Comparison (2017-2018)
Allergan Net Revenues and Net Loss (2014-2018)
Allergan Net Revenues by Segments (2018)
Allergan Net Revenues by Region (2018)
Pfizer Revenues and Net Income (2014-2018)
Pfizer Revenues by Segments (2018)
Pfizer Revenues by Region (2018)
Astellas Pharma Revenues and Profit (2015-2019)
Astellas Pharma Revenues by Segment (2019)
Astellas Pharma Revenues by Region (2019)
Hisamitsu Pharma Net Sales and Profit (2015-2019)
Hisamitsu Pharma Net Sales by Segments (2019)
Hisamitsu Pharma Net Sales by Region (2019)
Medtronic Net Sales and Net Income (2015-2019)
Medtronic Net Sales by Segment (2019)
Medtronic Net Sales by Region (2019)
Sumitomo Chemical (Urovant Sciences) Net Sales and Net Income (2015-2019)
Sumitomo Chemical (Urovant Sciences) Net Sales by Segments (2019)

  • Global Nanostructured Drug Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Nanostructured Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nanostructured Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanostructured Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumpt......
  • Global Silicone Foley Catheter Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Silicone Foley Catheter market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Silicone Foley Catheter volume and value at global level, regional level and company level. From a global perspective, this report represents overall Silicone Foley Catheter market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, appar......
  • Global Breast Cancer Therapeutics Drugs Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Breast Cancer Therapeutics Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Breast Cancer Therapeutics Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Breast Cancer Therapeutics Drugs market size by analyzing historical data and future prospect. Regionally, this report catego......
  • Global CD14 (Antibody) Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global CD14(Antibody) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CD14(Antibody) volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD14(Antibody) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and......
  • Global Rare Disease Drug Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Rare Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rare Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rare Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, e......
  • Global Ubiquitin Enzymes Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global Ubiquitin Enzymes market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ubiquitin Enzymes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ubiquitin Enzymes market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, e......
  • Global HS3S1 Antibody Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global HS3S1 Antibody market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on HS3S1 Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall HS3S1 Antibody market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and......
  • Global CASP7 Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global CASP7 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CASP7 volume and value at global level, regional level and company level. From a global perspective, this report represents overall CASP7 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of CASP7 in North A......
  • Global Pneumococcal Vaccines Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global Pneumococcal Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pneumococcal Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Vaccines market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs